Compounds > tobramycin
Page last updated: 2024-08-23

tobramycin and glucuronic acid

tobramycin has been researched along with glucuronic acid in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dorrington, SM; Nichols, WW; Slack, MP; Walmsley, HL1
Hostacká, A; Majtán, V1
Balzer, GJ; Givskov, M; Hentzer, M; Heydorn, A; Molin, S; Parsek, MR; Teitzel, GM1
Griswold, KE; Lamppa, JW1
Bandara, HM; Harb, A; Kolacny, D; Martins, P; Smyth, HD1
Abdelghany, SM; Deacon, J; Donnelly, RF; Elborn, JS; Gilmore, BF; Jones, DS; Kissenpfennig, A; Megaw, J; Quinn, DJ; Schmid, D; Scott, CJ; Taggart, CC1
Cao, B; Christophersen, L; Høiby, N; Jensen, PØ; Kolpen, M; Moser, C; Sams, T; Sneppen, K1

Other Studies

7 other study(ies) available for tobramycin and glucuronic acid

ArticleYear
Inhibition of tobramycin diffusion by binding to alginate.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:4

    Topics: Alginates; Binding Sites; Diffusion; Glucuronic Acid; Hexuronic Acids; Polysaccharides, Bacterial; Pseudomonas aeruginosa; Tobramycin; Tritium

1988
Influence of the postantibiotic effect and postantibiotic sub-MICs effect of netilmicin, tobramycin, ciprofloxacin and pefloxacin on alginate production by Pseudomonas aeruginosa.
    Folia microbiologica, 1996, Volume: 41, Issue:3

    Topics: Alginates; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Depression, Chemical; Dose-Response Relationship, Drug; Gentamicins; Glucuronic Acid; Hexuronic Acids; Humans; Microbial Sensitivity Tests; Netilmicin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Virulence

1996
Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function.
    Journal of bacteriology, 2001, Volume: 183, Issue:18

    Topics: Alginates; Anti-Bacterial Agents; Biofilms; Drug Resistance, Microbial; Glucuronic Acid; Hexuronic Acids; Humans; Pseudomonas aeruginosa; Tobramycin

2001
Alginate lyase exhibits catalysis-independent biofilm dispersion and antibiotic synergy.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:1

    Topics: Alginates; Amino Acids; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Drug Combinations; Drug Synergism; Escherichia coli; Glucuronic Acid; Hexuronic Acids; Humans; Kinetics; Microscopy, Electron, Scanning; Polysaccharide-Lyases; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Serum Albumin, Bovine; Tobramycin

2013
Sound waves effectively assist tobramycin in elimination of Pseudomonas aeruginosa biofilms in vitro.
    AAPS PharmSciTech, 2014, Volume: 15, Issue:6

    Topics: Acoustics; Alginates; Anti-Bacterial Agents; Biofilms; Drug Resistance, Bacterial; Gels; Glucuronic Acid; Hexuronic Acids; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Confocal; Pseudomonas aeruginosa; Sound; Surface Tension; Time Factors; Tobramycin; Vibration; Viscosity

2014
Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
    Journal of controlled release : official journal of the Controlled Release Society, 2015, Jan-28, Volume: 198

    Topics: Adult; Alginates; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Chitosan; Cystic Fibrosis; Deoxyribonuclease I; DNA; Glucuronic Acid; Hexuronic Acids; Humans; Microbial Sensitivity Tests; Nanoparticles; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sputum; Tobramycin; Treatment Outcome

2015
Diffusion Retardation by Binding of Tobramycin in an Alginate Biofilm Model.
    PloS one, 2016, Volume: 11, Issue:4

    Topics: Alginates; Anti-Bacterial Agents; Biofilms; Glucuronic Acid; Hexuronic Acids; Models, Chemical; Tobramycin

2016